Next, patients were stratified based on clinicopathological features, including WHO grade (II and III), 1p/19q status (co-deletion and intact), IDH status (mutation and wild-type), and histology (astrocytoma and oligoastrocytoma). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).